BioSpace News Archive

Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the European Academy of Dermatology and Venereology (EADV) 2021 Congress.

Phil, Inc. announces partnership with Impel NeuroPharma, Inc. (NASDAQ: IMPL) in support of Trudhesa™ (dihydroergotamine mesylate) nasal spray (0.725 mg per spray) to provide technology-powered patient support and distribution services through Phil’s proprietary workflow to enhance the patient’s access to therapy.

Hangzhou Chance Pharmaceuticals, a clinical-stage biotechnology company focusing on discovering, developing, and commercializing transformative inhalation therapies for the world’s most debilitating diseases, announced that it has appointed Guobao Zhao as Senior Vice President responsible for business development and corporate strategy.

ILiAD Biotechnologies, LLC (ILiAD) presented a breakthrough finding today on the effect of BPZE1, a live attenuated intranasal pertussis vaccine, on serum bactericidal activity (SBA) against PRN(+) and PRN(-) Bordetella pertussis strains at the virtual ID Week 2021 conference (sponsored by Infectious Disease Society of America).

Immutep Limited, a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce it has received a €2,126,617 research and development tax incentive payment in cash from the French Government under its Crédit d’Impôt Recherche scheme.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the launch of ProFound AI® Risk for digital breast tomosynthesis (DBT), or 3D mammography, as well as an updated version of PowerLook® Density Assessment.

Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that updates and baseline data from two ongoing Phase 2 and Phase 2/3 clinical trials of its lead development candidate ATH-1017.

Phosplatin Therapeutics Inc. today announced the appointment of Elizabeth Tallett to the company’s Board of Directors.

Peptilogics today presented Phase 1 safety and tolerability data on PLG0206, a unique engineered antibacterial peptide being developed for the treatment of prosthetic joint infection (PJI).

Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, today announced U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform.